Targeting Her-2+ Breast Cancer Cells with Bleomycin Immunoliposomes Linked to LLO
2012 · Molecular Pharmaceutics · 46 citations
https://doi.org/10.1021/mp300049n
T
Thomas J. Anchordoquy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
110
Papers
6.7K
Citations
42
h-index
72
i10-index
Thomas J. Anchordoquy is an academic researcher from CIBBIM-Nanomedicine. The author has contributed to research in topics: RNA Interference and Gene Delivery & Nanoparticle-Based Drug Delivery & Advanced biosensing and bioanalysis techniques. The author has an h-index of 42, co-authored 94 publications.
ORCID: 0000-0001-8599-4419Papers by this author
worksEscaping to silence using an endosome-disrupting polymer
2021 · Molecular Therapy · 1 citations
https://doi.org/10.1016/j.ymthe.2021.09.006
Supplementary material from "Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype"
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3911926.v1
HSP90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line*
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.4487621
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat